Literature DB >> 16107117

Safe and effective pharmacologic management of arrhythmias.

Mehdi Razavi1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16107117      PMCID: PMC1163475     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


× No keyword cloud information.
  5 in total

Review 1.  Antiarrhythmic therapy in atrial fibrillation: indications, guidelines, and safety.

Authors:  Armin Barekatain; Mehdi Razavi
Journal:  Tex Heart Inst J       Date:  2012

2.  Treatment of catecholaminergic polymorphic ventricular tachycardia in mice using novel RyR2-modifying drugs.

Authors:  Na Li; Qiongling Wang; Martha Sibrian-Vazquez; Robert C Klipp; Julia O Reynolds; Tarah A Word; Larry Scott; Guy Salama; Robert M Strongin; Jonathan J Abramson; Xander H T Wehrens
Journal:  Int J Cardiol       Date:  2016-10-29       Impact factor: 4.164

Review 3.  Maternal monitoring and safety considerations during antiarrhythmic treatment for fetal supraventricular tachycardia.

Authors:  Isabelle Malhamé; Christy Gandhi; Gofran Tarabulsi; Matthew Esposito; Kristin Lombardi; Antony Chu; Kenneth K Chen
Journal:  Obstet Med       Date:  2018-11-15

Review 4.  Inherited arrhythmic disorders: long QT and Brugada syndromes.

Authors:  Amirali Nader; Ali Massumi; Jie Cheng; Mehdi Razavi
Journal:  Tex Heart Inst J       Date:  2007

Review 5.  Cardiovascular Drugs and Osteoarthritis: Effects of Targeting Ion Channels.

Authors:  Raminta Vaiciuleviciute; Daiva Bironaite; Ilona Uzieliene; Ali Mobasheri; Eiva Bernotiene
Journal:  Cells       Date:  2021-09-28       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.